|
|
|
Treating Prostate Cancer in Men with Low Prostate-Specific Antigen Levels |
|
|
|
|
Posted by Dr. Johanne Perez M.D
|
|
Thursday, 26 August 2010 15:23 |
|
Most men had low-risk disease but received aggressive therapy.
Most prostate cancer is now detected at a localized stage, presumably because of screening for prostate-specific antigen (PSA), and the 5-year survival rate for patients with local disease is nearly 100%. Some experts are now concerned about overdiagnosis and overly aggressive treatment, yet others argue for lowering the PSA threshold for biopsy even further.
|
|
Read more...
|
|
Emerging Antibiotic Resistance in Enterobacteria Prompts Global Concern |
|
|
|
|
Posted by Dr. Johanne Perez M.D
|
|
Thursday, 26 August 2010 15:21 |
|
Physician's First Watch for August 12, 2010 David G. Fairchild, MD, MPH, Editor-in-Chief
Patients may ask about a widely reported study describing emerging bacterial resistance to certain antibiotics. The study, published in Lancet Infectious Diseases, shows that a gene in E. coli and K. pneumoniae confers resistance to carbapenem antibiotics, especially in patients from India and Pakistan.
Researchers describe 180 isolates from patients in India, Pakistan, the U.K., and other countries. The isolates produce an enzyme, New Delhi metallo-beta-lactamase 1 (NDM-1) whose gene can be carried both on bacterial chromosomes and plasmids. NDM-1 was identified in up to 44% of carbapenem-resistant isolates in U.K. patients, some of whom had undergone elective surgical procedures in India or Pakistan.
|
|
Read more...
|
|
Why Don't Implantable Cardioverter-Defibrillators Prevent Sudden Cardiac Death After Recent Myocardial Infarction? |
|
|
|
|
Posted by Dr. Johanne Perez M.D
|
|
Thursday, 26 August 2010 15:19 |
|
Recurrent MI and mechanical factors such as cardiac rupture may account for nearly 50% of SCD early after MI.
The risk for sudden cardiac death (SCD) is particularly high in the early months after a myocardial infarction (MI). However, two trials of prophylactic implantable cardioverter-defibrillator (ICD) placement after MI failed to show a survival benefit in ICD recipients, in contrast to results of other ICD trials. To examine this lack of benefit more closely, investigators studied data from VALIANT, an international trial of valsartan in MI survivors.
|
|
Read more...
|
|
Posted by Dr. Johanne Perez M.D
|
|
Thursday, 26 August 2010 15:18 |
|
A flavored oral formulation of glycopyrrolate is now FDA approved for severe drooling in children.
Chronic drooling in children and youth with neurological disorders can be a disabling symptom that affects swallowing and hygiene. It is often seen in patients with cerebral palsy and other neuromuscular and developmental conditions that adversely affect oropharyngeal muscle coordination and the elimination of oral secretions through effective swallowing.
|
|
Read more...
|
|
|
|
|
<< Start < Prev 1 2 Next > End >>
|
|
Page 1 of 2 |